Updated:
Sciety
Sciety is a partner for investors seeking opportunities in leading life science companies and for companies that need capital to take the next growth step.
Sciety
Sciety is a partner for investors seeking opportunities in leading life science companies and for companies that need capital to take the next growth step. Investors can invest together with Sciety in prominent companies within life science and digital health. Sciety has a strong dealflow of Nordic companies and a thorough selection process based on deep industry expertise, and engages long-term through active ownership.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
Europe
Country
Sweden
City
Stockholm
Corporate office
Stockholm, Sweden
Sector focus
Frequently asked questions
What does Sciety invest in?
Sciety focuses on early-stage life-science companies originating in the Nordic region. The portfolio targets drug development, diagnostics, medical devices, and digital-health platforms. Its position pages indicate an emphasis on precision oncology, including companies working on minimal residual disease detection.
How does Sciety source its deals?
Sciety concentrates on the Nordic life-science cluster, drawing origination from relationships with Karolinska Institutet, Swedish university hospitals, and regional biotech incubators. The proximity to Stockholm's research infrastructure provides access to spinouts and academic founders before they reach international syndicate desks.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: